Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000711377-23-000008
Filing Date
2023-04-27
Accepted
2023-04-27 13:44:40
Documents
1
Period of Report
2023-04-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3043
  Complete submission text file 0000711377-23-000008.txt   4339
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address
Lilly Jason Warren (Reporting) CIK: 0001790610 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17988 | Film No.: 23854840